Visualitza per autor "de Bono, Johann S"
Ara mostrant els elements 1-5 d 5
-
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Choudhury, Atish D.; Higano, Celestia; Cook, Natalie; Rathkopf, Dana E.; Wisinski, Kari; Martín Liberal, Juan Jesús; de Bono, Johann S (American Association for Cancer Research, 2022-06-01) -
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
Wilson, Brooke; Armstrong, Andrew J.; Sternberg, C. N.; Ryan, Charles; Scher, Howard I.; Carles Galceran, Joan; de Bono, Johann S (Elsevier, 2022-07) -
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; Fizazi, Karim; James, Nicholas D.; Mateo Valderrama, Joaquim; de Bono, Johann S (Elsevier, 2023-03) -
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial
Fizazi, Karim; Saad, Fred; Mateo, Joaquin; de Bono, Johann S; Shore, Neal; Sandhu, Shahneen (American Society of Clinical Oncology, 2024-02-10) -
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER
Joshua, Anthony; Armstrong, Andrew; Crumbaker, Megan; Scher, Howard I.; de Bono, Johann S; TOMBAL, Bertrand; Carles, Joan (Elsevier, 2022-07)